Contract facts
NONETO CARRY OUT DEVELOPMENT FOR A DRUG CANDIDATE SMALL MOLECULE INHIBITOR AGAINST CHIKUNGUNYA VIRUS, AN ALPHAVIRUS THAT CAUSES DEBILITATING AND SOMETIMES LIFE-THREATENING DISEASE IN HUMANS. is a federal NONE award for National Institutes Of Health Niaid held by Oregon Health & Science University. Estimated value $15M ($4.7M obligated). Current period of performance ends Dec 31, 2026 (potential Mar 4, 2027). Last award drew 10 bidders. Place of performance: PORTLAND OR. Related solicitation BAA2022-1.
TO CARRY OUT DEVELOPMENT FOR A DRUG CANDIDATE SMALL MOLECULE INHIBITOR AGAINST CHIKUNGUNYA VIRUS, AN ALPHAVIRUS THAT CAUSES DEBILITATING AND SOMETIMES LIFE-THREATENING DISEASE IN HUMANS.
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (132 days remaining). Agencies typically plan 12–18 months ahead — at 4.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordOregon Health & Science University — $69.0M obligated across 216 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93023C00002?
75N93023C00002 (CARRY OUT development for a DRUG) is a National Institutes Of Health Niaid award with a potential value of $15M, currently held by Oregon Health & Science University. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93023C00002?
National Institutes Of Health Niaid awarded 75N93023C00002 to Oregon Health & Science University (potential $15M).
Who is the incumbent on 75N93023C00002?
Oregon Health & Science University is the incumbent with $69.0M across 216 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does Oregon Health & Science University’s 75N93023C00002 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.